Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an oral tablet for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus, and is used in both hospital and community settings.

GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from comprehensive regulatory support and consistent product availability across multiple markets.

Linezolid is indicated for several serious Gram‑positive bacterial infections.

- Methicillin‑resistant Staphylococcus aureus (MRSA): effective treatment of skin, soft‑tissue and bloodstream infections caused by MRSA. - Community‑acquired pneumonia: provides coverage against susceptible Streptococcus pneumoniae and other typical pathogens. - Skin and soft‑tissue infections: resolves cellulitis, abscesses and wound infections caused by susceptible Gram‑positive organisms. - Hospital‑acquired infections: used for complicated infections where other agents may be ineffective.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: mild to moderate loose stools. - Headache: occasional tension‑type headache. - Metallic taste: transient alteration of taste perception.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count requiring monitoring. - Peripheral neuropathy: sensory changes that may be irreversible. - Serotonin syndrome: risk when combined with serotonergic agents.

Before initiating therapy, consider the following safety measures.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: assess liver enzymes periodically during treatment. - Concomitant serotonergic drugs: evaluate risk of serotonin syndrome. - Long‑term use: perform regular complete blood count monitoring. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Linezolid can interact with several medication classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): heightened serotonin toxicity. - Tyramine‑rich foods: potential hypertensive crisis.

Moderate Interactions (Monitor Closely): - Rifampin: may reduce linezolid plasma concentrations. - Warfarin: possible increase in INR, requiring closer coagulation monitoring. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may augment bleeding risk.